Comparison of Clinical Efficacy of Alectinib Versus Crizotinib in ALK-Positive Non-Small Cell Lung Cancer: A Meta-Analysis

Comparison of Clinical Efficacy of Alectinib Versus Crizotinib in ALK-Positive Non-Small Cell Lung Cancer: A Meta-Analysis

ObjectiveTo systematically evaluate the efficacy and safety of alectinib versus crizotinib in the treatment of anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer.MethodsStudies about the efficacy of alectinib versus crizotinib in the treatment of ALK-positive non-small cell lung ca...

Full description

Bibliographic Details
Main Authors: Hao Tang, Longyu Jin, Zhang Zhang, Zhibin Jiang, Zeeshan Malik
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
alectinib
crizotinib
ALK inhibitors
non-small cell lung cancer
efficacy and safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.646526/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.646526/full

Similar Items